Literature DB >> 36125540

A ratiometric fluorescence method based on nitrogen-doped carbon quantum dots for the determination of the activity of alkaline phosphatase.

Yuntai Lv1, Junyang Chen1, Xiaobin Zhou1, Xingguang Su2.   

Abstract

Herein, a simple and sensitive ratiometric fluorescence sensing platform to detect alkaline phosphatase (ALP) activity is developed on the basis of yellow fluorescent nitrogen-doped carbon quantum dots (YNCDs). The hydrolysis of ascorbic acid 2-phosphate (AAP) into ascorbic acid (AA) is catalyzed by ALP. Then, AA will react with o-phenylenediamine (OPD) to form 3-(1,2-dihydroxyethyl)furo[3,4b]-quinoxaline (QXD) which is a blue fluorescent quinoxaline derivative with emission at 435 nm in the presence of Cu2+. YNCDs have yellow fluorescence emission at 555 nm, and can maintain stable in QXD reaction system. Therefore, by utilizing the fluorescence of YNCDs at 555 nm as reference signal and the fluorescence of QXD at 435 nm as report signal, we can detect the ALP activity by monitoring the fluorescence ratio (F435/F555). The linear range is 0.5-5 U/L, and the limit of detection is 0.14 U/L. An application of this method for the analysis of ALP in human serum has given satisfactory results. A ratiometric fluorescent nanoprobe for ascorbic acid and alkaline phosphatase detection with excellent biocompatible and high sensitivity was successfully constructed based on YNCDs and QXD.
© 2022. Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Alkaline phosphatase; Carbon dots; Quinoxaline derivative; Ratiometric fluorescence

Year:  2022        PMID: 36125540     DOI: 10.1007/s00216-022-04329-4

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.478


  1 in total

1.   Alkaline phosphatase normalization is a biomarker of improved survival in primary sclerosing cholangitis.

Authors:  Moira Hilscher; Felicity B Enders; Elizabeth J Carey; Keith D Lindor; James H Tabibian
Journal:  Ann Hepatol       Date:  2016 Mar-Apr       Impact factor: 2.400

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.